Download Android Version
      




Manage your Employees, Payroll & Stock with Divine HRM. Click here for demo.

VenoStent has a new technology to improve outcomes for dialysis patients

Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients. Failed dialysis surgeries occur in roughly 55% to 65% of patients with end-stage renal disease, according to the company. Bouré had first started working on the technology at the heart of VenoStent's offering as part of his dissertation in 2012.








Top News